Expanding the Dynamic Range of microRNA Expression: Quantification from Liquid Biopsy
Improved nucleic acid quantitation from precious samples is a key driver for the concept of liquid biopsy. By quantifying miRNA from serum/plasma samples as well as biofluids such as cerebral spinal fluid, key biomarkers can be detected without the need for invasive tissue-based biopsy. In this online seminar recording of the Sept. 10 webinar, Jo Vandesompele of the Center for Medical Genetics at Ghent University provides an overview of the use of preamplification and minimum sample inputs to maximize the dynamic range of miRNA expression studies. Jon Shaffer of QIAGEN follows with a discussion of microRNA detection technology and platform comparison. Watch it on-demand!
Improved nucleic acid quantitation from precious samples is a key driver for the concept of liquid biopsy. By quantifying miRNA from serum/plasma samples as well as biofluids such as cerebral spinal fluid, key biomarkers can be detected without the need for invasive tissue-based biopsy. In this online seminar recording of the Sept. 10 webinar, Jo Vandesompele of the Center for Medical Genetics at Ghent University provides an overview of the use of preamplification and minimum sample inputs to maximize the dynamic range of miRNA expression studies. Jon Shaffer of QIAGEN follows with a discussion of microRNA detection technology and platform comparison. Watch it on-demand!
Hide details